The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex
- PMID: 26849906
- PMCID: PMC6379054
- DOI: 10.1016/j.semcdb.2016.01.040
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complex
Abstract
Understanding the development and function of the nervous system is one of the foremost aims of current biomedical research. The nervous system is generated during a relatively short period of intense neurogenesis that is orchestrated by a number of key molecular signalling pathways. Even subtle defects in the activity of these molecules can have serious repercussions resulting in neurological, neurodevelopmental and neurocognitive problems including epilepsy, intellectual disability and autism. Tuberous sclerosis complex (TSC) is a monogenic disease characterised by these problems and by the formation of benign tumours in multiple organs, including the brain. TSC is caused by mutations in the TSC1 or TSC2 gene leading to activation of the mechanistic target of rapamycin (mTOR) signalling pathway. A desire to understand the neurological manifestations of TSC has stimulated research into the role of the mTOR pathway in neurogenesis. In this review we describe TSC neurobiology and how the use of animal model systems has provided insights into the roles of mTOR signalling in neuronal differentiation and migration. Recent progress in this field has identified novel mTOR pathway components regulating neuronal differentiation. The roles of mTOR signalling and aberrant neurogenesis in epilepsy are also discussed. Continuing efforts to understand mTOR neurobiology will help to identify new therapeutic targets for TSC and other neurological diseases.
Keywords: Epilepsy; Neural stem cell; Neuronal differentiation; Neuronal migration; TSC; mTOR.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.Int J Dev Neurosci. 2013 Nov;31(7):667-78. doi: 10.1016/j.ijdevneu.2013.02.008. Epub 2013 Feb 26. Int J Dev Neurosci. 2013. PMID: 23485365 Free PMC article. Review.
-
Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells.J Proteomics. 2023 Jul 15;283-284:104928. doi: 10.1016/j.jprot.2023.104928. Epub 2023 May 18. J Proteomics. 2023. PMID: 37207814
-
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.Int J Mol Sci. 2018 May 16;19(5):1474. doi: 10.3390/ijms19051474. Int J Mol Sci. 2018. PMID: 29772672 Free PMC article. Review.
-
Tuberous sclerosis--A model for tumour growth.Semin Cell Dev Biol. 2016 Apr;52:3-11. doi: 10.1016/j.semcdb.2016.01.025. Epub 2016 Jan 24. Semin Cell Dev Biol. 2016. PMID: 26816112 Review.
-
High glucose concentrations mask cellular phenotypes in a stem cell model of tuberous sclerosis complex.Epilepsy Behav. 2019 Dec;101(Pt B):106581. doi: 10.1016/j.yebeh.2019.106581. Epub 2019 Nov 21. Epilepsy Behav. 2019. PMID: 31761686 Free PMC article.
Cited by
-
The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.Int J Mol Sci. 2019 Aug 5;20(15):3824. doi: 10.3390/ijms20153824. Int J Mol Sci. 2019. PMID: 31387280 Free PMC article. Review.
-
Activated PI3Kδ syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model.Brain Behav Immun Health. 2021 Oct 19;18:100377. doi: 10.1016/j.bbih.2021.100377. eCollection 2021 Dec. Brain Behav Immun Health. 2021. PMID: 34786564 Free PMC article.
-
Mechanistic target of rapamycin signaling in human nervous system development and disease.Front Mol Neurosci. 2022 Sep 26;15:1005631. doi: 10.3389/fnmol.2022.1005631. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36226315 Free PMC article. Review.
-
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.PLoS Genet. 2016 Aug 5;12(8):e1006242. doi: 10.1371/journal.pgen.1006242. eCollection 2016 Aug. PLoS Genet. 2016. PMID: 27494029 Free PMC article.
-
The endogenous progenitor response following traumatic brain injury: a target for cell therapy paradigms.Neural Regen Res. 2022 Nov;17(11):2351-2354. doi: 10.4103/1673-5374.335833. Neural Regen Res. 2022. PMID: 35535870 Free PMC article. Review.
References
-
- Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14:733–745. - PubMed
-
- Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci. 2013;16:1537–1543. - PubMed
-
- O’Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998;351:1490. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous